Low‐grade myofibroblastic sarcoma: A population‐based study

Low‐grade myofibroblastic sarcoma: A population‐based study

Objectives/Hypothesis Low‐grade myofibroblastic sarcoma (LGMS) is a rare entity that is described as having a predilection for occurring in the head and neck region. Here we analyze its demographics, clinic‐pathologic, and survival characteristics. Study Design Retrospective database analysis. Metho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2017-01, Vol.127 (1), p.116-121
Hauptverfasser: Chan, Jason Y. K., Gooi, Zhen, Wong, Eddy W. Y., Ng, Siu K., Tong, Michael C. F., Vlantis, Alexander C.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Diagnosis, Differential
Extremities - pathology
Female
Fibrosarcoma - epidemiology
Fibrosarcoma - pathology
Fibrosarcoma - therapy
Head and Neck Neoplasms - epidemiology
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - therapy
Humans
Laryngoscopy
Low‐grade myofibroblastic sarcoma
Male
Middle Aged
myofibroblastic sarcoma
Myosarcoma - epidemiology
Myosarcoma - pathology
Myosarcoma - therapy
Neoplasm Grading
Neoplasm Staging
Population-based studies
Retrospective Studies
Sarcoma
SEER Program
Survival Rate
United States - epidemiology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives/Hypothesis Low‐grade myofibroblastic sarcoma (LGMS) is a rare entity that is described as having a predilection for occurring in the head and neck region. Here we analyze its demographics, clinic‐pathologic, and survival characteristics. Study Design Retrospective database analysis. Methods A cohort from the Surveillance, Epidemiology, and End Results Program database of cases with LGMS between 2001 and 2012. Results There were 49 cases with a 5‐year overall survival of 71.6% and disease‐ specific survival of 76.3%. The majority of cases were in patients
ISSN:0023-852X
1531-4995
DOI:10.1002/lary.26146